ArticlePharmaceutics2026

Synergistic Cancer Immunotherapy by Inducing Immunogenic Cell Death and Blocking the CD39-Adenosine Pathway Using a Nanoplatform.

Yiwen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.